Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for SVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 -0.189M
March 31, 2026 0.195M
December 31, 2025 -135.56M
September 30, 2025 0.024M
June 30, 2025 0.049M
March 31, 2025 0.05M
December 31, 2024 0.843M
September 30, 2024 -118.32M
June 30, 2024 -0.009M
March 31, 2024 -0.049M
December 31, 2023 -7.895M
September 30, 2023 -74.76M
June 30, 2023 -0.104M
March 31, 2023 -0.026M
December 31, 2022 -0.002M
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 -0.084M
September 30, 2021 -0.01M
June 30, 2021 -0.324M
March 31, 2021 -124.38M
December 31, 2020 0.00
September 30, 2020 -1.827M
June 30, 2020 -2.328M
Date Value
March 31, 2020 -0.048M
December 31, 2019 -25.25M
September 30, 2019 -5.708M
June 30, 2019 -19.10M
March 31, 2019 -4.896M
December 31, 2018 -0.02M
September 30, 2018 -45.81M
June 30, 2018 -0.031M
March 31, 2018 -0.514M
December 31, 2017 -50.76M
September 30, 2017 -0.89M
June 30, 2017 -40.01M
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 -0.006M
June 30, 2016 6.682M
March 31, 2016 -7.459M
December 31, 2015 0.013M
September 30, 2015 0.02M
June 30, 2015 -2.035M
March 31, 2015 0.004M
December 31, 2014 -19.53M
September 30, 2014 -2.291M
June 30, 2014 -4.181M
March 31, 2014 -8.293M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. 346.00M
Insmed, Inc. -28.01M
United Therapeutics Corp. -126.30M
Vertex Pharmaceuticals, Inc. 421.80M
SELLAS Life Sciences Group, Inc. -38.83M